Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | MTOR | P42345 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | TP53 | P04637 | 2/20 | 0.59 |
| ▸ | THRB | P10828 | 1/20 | 0.59 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.59 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.59 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.59 |
| ▸ | GMNN | O75496 | 1/20 | 0.59 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.59 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.59 |
| ▸ | THPO | P40225 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
| ▸ | BLM | P54132 | 1/20 | 0.59 |
| ▸ | HBB | P68871 | 1/20 | 0.59 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL453967 | 1.00 | LMNA (0.59) | LMNAMTORALDH1A1TP53THRB | |
| SCHEMBL14853910 | 1.00 | LMNA (0.59) | LMNAMTORALDH1A1TP53THRB | |
| SCHEMBL16974936 | 0.92 | LMNA (0.51) | LMNAMTORALDH1A1TP53THRB | |
| SCHEMBL18513007 | 0.90 | LMNA (0.47) | LMNAMTORALDH1A1TP53THRB | |
| SCHEMBL11317700 | 0.89 | LMNA (0.58) | LMNAMTORALDH1A1TP53THRB | |
| SCHEMBL2584925 | 0.89 | LMNA (0.58) | LMNAMTORALDH1A1TP53THRB | |
| SCHEMBL11317699 | 0.89 | LMNA (0.58) | LMNAMTORALDH1A1TP53THRB | |
| SCHEMBL16805382 | 0.89 | LMNA (0.58) | LMNAMTORALDH1A1TP53THRB | |
| SCHEMBL11331733 | 0.89 | LMNA (0.58) | LMNAMTORALDH1A1TP53THRB | |
| SCHEMBL16809039 | 0.89 | LMNA (0.58) | LMNAMTORALDH1A1TP53THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5270 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12636304-B2 | — | — | 2026-05-26 | — | — | US | claimed |
| US-20260139030-A1 | CHIMERIC PROTEINS FOR TREATING CUTANEOUS INFLAMMATION | SHATTUCK LABS INC (US) | 2026-05-21 | — | — | US | claimed |
| US-12618064-B2 | Acetylated ribonucleic acids and uses thereof | HELIX NANOTECHNOLOGIES INC (US) | 2026-05-05 | — | — | US | claimed |
| WO-2026089664-A1 | GENERALISED FRAMEWORK FOR IDENTIFICATION OF RNA MODIFICATION ON SPECIFIC SEQUENCES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2026-04-30 | — | — | WO | claimed |
| US-20260108554-A1 | METHODS FOR REPROGRAMMING AND GENE EDITING CELLS | FACTOR BIOSCIENCE INC (US) | 2026-04-23 | — | — | US | claimed |
| US-12606866-B2 | Methods for the amplification of bisulfite-treated DNA | THE UNIVERSITY OF CHICAGO (US) | 2026-04-21 | — | — | US | claimed |
| US-20260103701-A1 | TET-ASSISTED PYRIDINE BORANE SEQUENCING | EXACT SCIENCES INNOVATION LTD (GB) | 2026-04-16 | — | — | US | claimed |
| US-12601006-B2 | Targeted, long-read nucleic acid sequencing for the determination of cytosine modifications | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD. (CH) | 2026-04-14 | — | — | US | claimed |
| EP-4720279-A2 | CIS-REGULATORY ELEMENTS OF TRANSLATION AND METHODS USING SAME | Yale University (US) | 2026-04-08 | — | — | EP | claimed |
| EP-4716748-A2 | METHOD OF MODULATING MRNA TRANSLATION | Yale University (US) | 2026-04-01 | — | — | EP | claimed |
| WO-2013151672-A2 | MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF ONCOLOGY-RELATED PROTEINS AND PEPTIDES | modeRNA Therapeutics (US) | 2013-10-10 | — | — | WO | claimed |
| WO-2013151671-A1 | MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF COSMETIC PROTEINS AND PEPTIDES | modeRNA Therapeutics (US) | 2013-10-10 | — | — | WO | claimed |
| WO-2013151736-A2 | IN VIVO PRODUCTION OF PROTEINS | modeRNA Therapeutics (US) | 2013-10-10 | — | — | WO | claimed |
| EP-2578685-A2 | RNA containing modified nucleosides and methods of use thereof | The Trustees of The University of Pennsylvania (US) | 2013-04-10 | — | — | EP | claimed |
| WO-2013039861-A2 | ENGINEERED NUCLEIC ACIDS AND METHODS OF USE THEREOF | modeRNA Therapeutics (US) | 2013-03-21 | — | — | WO | claimed |
| WO-2012158736-A1 | ENGINEERED NUCLEIC ACIDS AND METHODS OF USE THEREOF FOR NON-HUMAN VERTEBRATES | modeRNA Therapeutics (US) | 2012-11-22 | — | — | WO | claimed |
| US-20120251618-A1 | DELIVERY AND FORMULATION OF ENGINEERED NUCLEIC ACIDS | modeRNA Therapeutics (US) | 2012-10-04 | — | — | US | claimed |
| WO-2012135805-A2 | DELIVERY AND FORMULATION OF ENGINEERED NUCLEIC ACIDS | modeRNA Therapeutics (US) | 2012-10-04 | — | — | WO | claimed |
| EP-2201118-B1 | COMPOSITIONS AND METHODS FOR THE IDENTIFICATION OF INHIBITORS OF RETROVIRAL INFECTION | TRANA DISCOVERY (US) | 2012-04-18 | — | — | EP | claimed |
| CN-101855351-A | Compositions and methods for the identification of inhibitors of retroviral infection | TRANA DISCOVERY | 2010-10-06 | — | — | CN | claimed |